April 8, 2026

ECOG-ACRIN vice chair Dr. Al Benson discusses the evolving role of first-line immunotherapy for advanced anal cancer, referencing the InterAACT-2 and EA2176 trials

April 8, 2026

Group co-chair Dr. Mitchell Schnall named a health system chief digital officer to know in 2026

March 30, 2026

The March 2026 News from ECOG-ACRIN blog is now available

March 24, 2026

ECOG-ACRIN study finds inferior survival among Black patients with AML, independent of cytogenetic risk

February 27, 2026

The February 2026 News from ECOG-ACRIN blog is now available

February 13, 2026

The Winter 2026 advocacy blog Considering Clinical Trials is now available

February 9, 2026

Natasha Edwin, MD, community co-chair of the ECOG-ACRIN Myeloma Committee, highlights why patients in rural areas need access to quality clinical trials

February 3, 2026

ECOG-ACRIN legacy lung cancer studies E1594 and E5508 cited in ASCO Living Guideline 2026.3.0, therapy for stage 4 NSCLC without driver alterations

January 31, 2026

The January 2026 News from ECOG-ACRIN blog is now available

ECOG-ACRIN Cancer Research Group